Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,165 total articles
ON24 Inc. CEO Sharat Sharan sold 15,679 shares of common stock for $125,610 under a pre-arranged Rule 10b5-1 plan to satisfy tax withholding from restricted stock unit vesting. The sale, reported on a Form 4 filed March 2, 2026, occurred as the company’s stock traded near its 52-week high and while ON24 has agreed to be acquired by Cvent in an all-…
Fold Holdings Chief Financial Officer Wolfe Repass completed sales of 22,852 common shares on February 26 and 27, 2026, to satisfy tax withholding related to restricted stock unit vesting. The disposals, executed at prices between $1.463 and $1.479, generated roughly $33,579 in proceeds. The SEC filing also shows Repass converted 65,776 restricted …
Rackspace Technology Chief Human Resources Officer Kellie Teal-Guess sold 21,266 shares on March 2, 2026, to satisfy tax liabilities tied to vesting restricted stock units. The sale, executed under a Rule 10b5-1 plan adopted in September 2023, generated roughly $38,491 at trade prices between $1.75 and $1.89. Since the sale the stock has climbed to…
Rackspace Technology EVP and President of Public Cloud sold 45,393 shares on March 2, 2026, in a sell-to-cover transaction tied to restricted stock unit vesting. The trade, executed under a pre-arranged Rule 10b5-1 plan, generated approximately $82,161. The stock has climbed sharply in the last week and the company reported Q4 2025 results that out…
Rackspace Technology CFO Mark A. Marino sold 20,183 shares on March 2, 2026, to meet tax obligations tied to vested restricted stock units. The trades, carried out under a Rule 10b5-1 plan established in September 2023, totaled roughly $36,531. The transaction coincided with substantial recent stock gains after the company reported a better-than-ex…
Trent G. Kamke, Senior Vice President of Operations at LeMaitre Vascular Inc., reported the sale of 1,044 shares on February 27, 2026, netting $115,142 as the company's stock traded close to its 52-week peak. The activity followed related transactions to cover tax obligations and the settlement of a prior Performance Share Unit award. The insider m…
Navitas Semiconductor CFO Todd Glickman disposed of 12,532 shares of Class A common stock on February 26, 2026, for roughly $123,064 while also acquiring 32,636 shares at no cost the same day. The transactions leave Glickman with 833,383 directly held shares. The company recently disclosed the CFO's planned departure, a high-efficiency DC-DC power …
Indie Semiconductor Chief Executive Officer Donald McClymont sold 90,644 shares of Class A Common Stock on March 2, 2026 for $3.5617 per share, generating $322,846 in proceeds. On the same day he exercised options to acquire 186,835 shares upon the vesting of Restricted Stock Units. The stock trades at $3.39 and carries a beta of 2.54, while the co…
GigaCloud Technology Inc’s Chief Executive Officer Lei Wu, acting through related entities, sold 152,560 Class A Ordinary Shares for roughly $7.07 million across transactions on Feb. 26, 27 and March 2, 2026. The sales were executed under a pre-established 10b5-1 plan. The stock has shown strong recent gains and the company reported an earnings and…
Dolphin Entertainment Chief Executive Officer William O’Dowd IV filed a Form 4 disclosing a purchase of 3,100 shares on March 2, 2026, for roughly $4,991. The transaction occurred as the stock has climbed about 50% over the prior year and follows a quarter of organic revenue expansion and positive GAAP operating income.
Netflix Chief Financial Officer Spencer Adam Neumann sold 57,260 shares of Netflix on February 27, 2026, in two tranches for roughly $5.46 million and exercised options to acquire the same number of shares that day. The stock is trading near those sale prices, while recent corporate developments include a $2.8 billion termination fee tied to a canc…
Vertiv Holdings Co director Steven Reinemund sold 91,617.3 Class A shares on February 26, 2026, generating $25.39 million at prices between $250.14 and $259.09. The disposition took place while VRT traded close to its 52-week peak and as the company navigates strong EBITDA trends, a recent S&P upgrade, and elevated valuation metrics.
Universal Technical Institute Chief Executive Officer Jerome Alan Grant sold 60,040 shares of the company's common stock on February 27, 2026, for roughly $2.10 million. The transaction occurred as UTI shares traded close to their 52-week high and follows mixed first-quarter fiscal 2026 results that included a slight EPS miss but a revenue beat. An…
M&T Bank Corp Senior Executive Vice President Michael A. Wisler sold 8,236.977 shares of common stock on February 26, 2026, for $1,840,809 and exercised options to acquire 4,751 shares with a total exercise value of $702,438. The transactions occurred amid the bank’s fourth-quarter earnings beat, a declared quarterly dividend and a regional leaders…
Fluor Corp Chief Financial Officer John C. Regan sold $1,504,061 of company stock on February 26 and 27, 2026, after exercising options to acquire 16,773 shares at $17.96. The transactions, disclosed on a Form 4 filing, were executed in multiple tranches at prices ranging roughly between $50.96 and $53.32. After the sales Regan retains 103,859 shar…
IDEAYA Biosciences director Jeffrey Stein purchased 50,000 common shares on March 2, 2026, investing $1.65 million. The transaction leaves Stein with 54,281 shares directly and an additional 3,363 shares held indirectly by his son. The insider buy comes as IDEAYA trades near its assessed fair value and as the company reports clinical and leadership…
Interactive Communications International, Inc. reported a sale of 17,610 shares of Giftify, Inc. (NASDAQ: GIFT) on February 26, 2026, at a weighted average price of $0.934 for a total of $16,447. The trade reduced the company's position but left it with 2,577,760 shares. The transaction was also reported by HI Technology Corp and Merrill Brooks Smi…
Dakota Gold (NYSE: DC) Vice President of Exploration James McCoy Berry sold 12,388 shares on February 27, 2026, to meet tax obligations tied to the vesting of performance share units. The sale occurred near the stock's 52-week high, while Berry simultaneously converted multiple tranches of PSUs into common shares and exercised a large block of opti…
InfuSystem Holdings' Executive Vice President and CFO Barry G. Steele purchased 2,064 shares on March 2, 2026, at $9.16 per share, a $18,906 investment that followed a subsequent rise in the stock to $9.29. The insider transaction brings Steele's direct holdings to 88,000 shares. Separately, the company posted fourth-quarter 2025 earnings that beat…
Michael A. Plater, a director at Lincoln Educational Services (LINC), sold 17,256 shares on March 2, 2026, for about $616,556 in multiple open-market transactions. The company reported fourth-quarter 2025 revenue of $142.9 million, beating a $132.8 million forecast, and EPS of $0.40, in line with expectations. Following the sale, Plater directly ho…
Oruka Therapeutics Chief Operating Officer Laura Lee Sandler sold 5,000 shares of company stock on March 2, 2026, generating $167,821 in proceeds across two trades, and concurrently exercised employee warrants to acquire 5,000 additional shares for $39,000. The transactions occurred under a pre-arranged Rule 10b5-1 plan and follow a period of subst…
LifeVantage Corp director Dayton Judd purchased 33,197 shares across three transactions between February 26 and March 2, 2026, spending $152,422. The purchases, disclosed on a Form 4 filing with the SEC, leave Judd with 80,359 directly owned shares and 749,325 indirectly held through Sudbury Capital Fund, LP. The trades arrive amid a fiscal Q2 repo…
Contineum Therapeutics Chief Scientific Officer Lorrain Daniel S. sold 4,170 shares of Class A common stock on March 2, 2026, under a pre-arranged 10b5-1 trading plan. The transaction occurred as the company's shares traded near a 52-week high and following clinical trial results that prompted an analyst downgrade. Separately, Contineum priced an u…
Contineum Therapeutics' Chief Medical Officer and Head of Development, Tim Watkins, sold 3,611 Class A shares on March 2, 2026, at a weighted average price of $15.0153 and simultaneously exercised 3,611 options at $4.50. The company announced an upsized public offering priced at $12.25 per share and faces a recent analyst downgrade following mixed …
Daniel Breeze, senior vice president of corporate development at Royal Gold Inc., disposed of 1,400 shares of the company on March 2, 2026, realizing roughly $421,211 across two trades. The sale occurred while Royal Gold shares hovered close to a 52-week peak, following material restricted stock unit vesting earlier in the week. The company reporte…
